Trulieve Cannabis financials
$11.60+0.52%
Close Nov 4, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 |
|---|---|
| Revenue | $271.0M |
| Gross profit | $162.3M |
| Gross margin | 59.9% |
| Operating income | -$370.5M |
| Net income | -$406.0M |
| Net margin | −149.8% |
| Diluted EPS | $-2.10 |
| EBITDA | $74.0M |
| Operating cash flow | $53.1M |
| Free cash flow | $32.1M |
| Diluted shares | 192.7M |
Balance sheet
| Period end | Jun 30 |
|---|---|
| Cash & equivalents | $325.4M |
| Short-term investments | $0.00 |
| Total debt | $480.2M |
| Total assets | $2.08B |
| Total liabilities | $1.31B |
| Shareholders' equity | $765.9M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology